BlueRock Therapeutics Adds Min Wang to C-Suite

Xconomy Boston — 

Min Wang has been appointed chief legal and administrative officer of Cambridge, MA-based BlueRock Therapeutics. Wang was most recently general counsel and corporate secretary of Agios Pharmaceuticals (NASDAQ: AGIO). Her experience also includes posts at Genentech and Merck (NYSE: MRK). BlueRock, which develops regenerative medicines for tough-to-treat diseases, launched in late 2016 backed by $225 million in funding.